Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

2 Biotech Stocks Under $10 Wall Street Predicts Will Triple in Price

Published 12/10/2021, 08:41 AM
Updated 12/10/2021, 09:31 AM
© Reuters.  2 Biotech Stocks Under $10 Wall Street Predicts Will Triple in Price

© Reuters. 2 Biotech Stocks Under $10 Wall Street Predicts Will Triple in Price

An increasing focus on integrating advanced technologies into research efforts to generate viable drugs for treating various critical ailments, and growing demand for therapies from an aging population, should boost the biotech industry's growth. Given this backdrop, Wall Street analysts expect two low-priced biotech stocks—Esperion Therapeutics (NASDAQ:ESPR) and CTI BioPharma (NASDAQ:CTIC)—to deliver exceptional returns in the near term. Please read on for an explanation.In addition to helping the world combat the deadly COVID-19 virus, biotech companies are now working on producing viable medications and cures to treat other diseases by integrating advanced technologies. Furthermore, with an aging population heightening the demand for healthcare, the sector is poised to witness tremendous growth in the foreseeable future.

Also, the recently identified highly transmissible COVID-19 omicron variant could attract even more investor interest in the industry. The global biotechnology industry is projected to reach $2.44 trillion by 2028, registering a 15.8% CAGR.

Given the industry's solid growth prospects, Wall Street analysts expect quality biotech stocks Esperion Therapeutics Inc. (ESPR) and CTI BioPharma Corp. (CTIC), which are currently trading at less than $10, to deliver significant upside in the coming months. So, we think these stocks could be great additions to one's watchlist.

Continue reading on StockNews

Latest comments

buy
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.